Are you an aggressive or assertive manager?

      Learn how to handle authority...

Life on the Fast Track – Accelerated Learning

I noticed in the PF Company Perception, Motivation and Satisfaction 2003 Survey that development appeared as one of the top four answers to the...

The Matrix – 50 Things You (and your customers) ought to know about the...

CONTRACT FACTS 40-45! 40. Selling in Mental Health: There are only 41 points available for mental health as a therapeutic topic but interestingly another...

ABPI

Britain’s pharmaceutical industry invested a record £10 million a day in the search for new medicines last year and generated a best-ever annual trade...

EFFECTIVE PERFORMANCE MANAGEMENT

In many ways there are no secrets to implementing effective performance management. Performance Management is a process and a...

The 80/20 Rule

    The 80/20 Rule and how it fits into every business ...

the magic monitor

      If there were some magical way to predict swings in sales fortune, you might imagine that sales people and...

Leading the modern practice the ever-expanding role of the Practice Manager

A year ago, the leading editorial in the British Medical Journal heralded the opportunities for improving health outcomes with the new GMS contract but...

Therapy focus: Leukaemia

Leukaemia is a type of cancer which affects the blood cells. In the UK, leukaemia is the 12th most common cancer in adults, affecting...

Revving up for the Adenoviral-P53 Gene Therapy

 By Curt Herberts, Research Analyst, Frost & Sullivan, North America While gene therapy has been on the scientific horizon for a few decades, only...

Latest articles

Image of a man pumping air into a pund symbol to indicate drug firms admitting to colluding to keep up prices of antidepressants

Drug firms admit to colluding to keep up prices of antidepressants

Drug firms admit to colluding in order to keep up prices of antidepressants according to the Competition and Markets Authority (CMA). Two suppliers of the...
Licensing status of Avastin updated by MHRA

Licensing status of Avastin updated by MHRA

The licensing status of Avastin has been updated by the Medicines and Healthcare products Regulatory Agency (MHRA). The update concerns the licensing status of Avastin (bevacizumab)...
PM Society Digital Award Winners

PM Society Digital Award Winners 2019

Thursday 19th September saw the tenth PM Society Digital Awards take place at The Brewery in London. Around 500 guests sat down to dinner...

Popular articles

pain relief patch released by nurofen

Nurofen launches a 24 hour ibuprofen pain relief patch

Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen.  Despite body pain being among the most commonly...
Licensing status of Avastin updated by MHRA

Licensing status of Avastin updated by MHRA

The licensing status of Avastin has been updated by the Medicines and Healthcare products Regulatory Agency (MHRA). The update concerns the licensing status of Avastin (bevacizumab)...
PM Society Digital Award Winners

PM Society Digital Award Winners 2019

Thursday 19th September saw the tenth PM Society Digital Awards take place at The Brewery in London. Around 500 guests sat down to dinner...
Image of a man pumping air into a pund symbol to indicate drug firms admitting to colluding to keep up prices of antidepressants

Drug firms admit to colluding to keep up prices of antidepressants

Drug firms admit to colluding in order to keep up prices of antidepressants according to the Competition and Markets Authority (CMA). Two suppliers of the...
image of a hospital and ambulance showing poor diabetes control costs the NHS £3bn in avoidable treatment

Poor diabetes control costs the NHS £3bn in avoidable treatment

New research finds that poor diabetes control costs the NHS £3bn in potentially avoidable hospital treatment in England. The findings, being presented at this year’s...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription